{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:27:45Z","timestamp":1718152065429},"reference-count":41,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14458","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:44:26Z","timestamp":1715769866000},"source":"Crossref","is-referenced-by-count":0,"title":["Lymph node myeloid sarcoma with TP53\u2011associated myelodysplastic syndrome: A case report\u00a0"],"prefix":"10.3892","volume":"28","author":[{"given":"Mengke","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang 310006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"key20240611104502_b1-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20240611104502_b2-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1038\/s41598-022-10831-7","article-title":"Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"key":"key20240611104502_b3-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: Presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20240611104502_b4-ol-28-1-14458","first-page":"100286","article-title":"Bladder myeloid sarcoma with TP53 mutated myelodysplastic syndrome\/myeloproliferative neoplasm overlap syndrome: Response to Decitabine-Venetoclax regimen","volume":"17","author":"Mandhan","year":"2021","journal-title":"Leuk Res Rep"},{"key":"key20240611104502_b5-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"key20240611104502_b6-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: A single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"key":"key20240611104502_b7-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Tallman, Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: Analysis of patients in ECOG-ACRIN cancer research group trials, 1980\u20132008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"key":"key20240611104502_b8-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.prp.2016.06.014","article-title":"Clinicopathological features of myeloid sarcoma: Report of 39 cases and literature review","volume":"212","author":"Wang","year":"2016","journal-title":"Pathol Res Pract"},{"key":"key20240611104502_b9-ol-28-1-14458","first-page":"6194","article-title":"Mutation spectrum of the p53 gene in bone and soft tissue sarcomas","volume":"52","author":"Toguchida","year":"1993","journal-title":"Cancer Res"},{"key":"key20240611104502_b10-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pharmthera.2019.06.010","article-title":"TP53 in bone and soft tissue sarcomas","volume":"202","author":"Thoenen","year":"2019","journal-title":"Pharmacol Ther"},{"key":"key20240611104502_b11-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/gcc.22086","article-title":"Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma","volume":"52","author":"Ortiz-Cuaran","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"key20240611104502_b12-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and Decitabine in acute myeloid leukemia and Myelodysplastic Syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"key":"key20240611104502_b13-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"2247898","DOI":"10.1080\/16078454.2023.2247898","article-title":"Clinical characteristics, treatment options, and prognosis of myeloid sarcoma: Analysis using the SEER database","volume":"28","author":"Liang","year":"2023","journal-title":"Hematology"},{"key":"key20240611104502_b14-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12288-017-0807-y","article-title":"Myeloid sarcoma presented as generalized lymphadenopathy: Mimicking malignant lymphoma","volume":"34","author":"Gajendra","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"key20240611104502_b15-ol-28-1-14458","first-page":"3524","article-title":"A case of gastric granulocytic sarcoma misdiagnosed as non Hodgkin's lymphoma","volume":"37","author":"Fang","year":"2016","journal-title":"Int J Lab Med"},{"key":"key20240611104502_b16-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key20240611104502_b17-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"key":"key20240611104502_b18-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","article-title":"Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: An exploratory proof-of-mechanism study","volume":"13","author":"Ray-Coquard","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20240611104502_b19-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"2016752","DOI":"10.1155\/2017\/2016752","article-title":"Synovial sarcoma of the head and neck: A single institution review","volume":"2017","author":"Gopalakrishnan","year":"2017","journal-title":"Sarcoma"},{"key":"key20240611104502_b20-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5045\/br.2017.52.3.184","article-title":"Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: A single-institution experience","volume":"52","author":"Lee","year":"2017","journal-title":"Blood Res"},{"key":"key20240611104502_b21-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"351","DOI":"10.7326\/0003-4819-123-5-199509010-00005","article-title":"Isolated chloroma: The effect of early antileukemic therapy","volume":"123","author":"Imrie","year":"1995","journal-title":"Ann Intern Med"},{"key":"key20240611104502_b22-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1002\/cncr.33689","article-title":"Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax","volume":"127","author":"Kim","year":"2021","journal-title":"Cancer"},{"key":"key20240611104502_b23-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-3-642-54490-3_18","article-title":"Decitabine","volume":"201","author":"Hackanson","year":"2014","journal-title":"Recent Results Cancer Res"},{"key":"key20240611104502_b24-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00277-016-2870-0","article-title":"Evidence for a role of decitabine in the treatment of myeloid sarcoma","volume":"96","author":"Gornicec","year":"2017","journal-title":"Ann Hematol"},{"key":"key20240611104502_b25-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbrc.2005.03.190","article-title":"p53 mutation heterogeneity in cancer","volume":"331","author":"Soussi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20240611104502_b26-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"17968","DOI":"10.18632\/oncotarget.4956","article-title":"Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice","volume":"6","author":"Goh","year":"2015","journal-title":"Oncotarget"},{"key":"key20240611104502_b27-ol-28-1-14458","first-page":"5131","article-title":"De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line","volume":"19","author":"Asada","year":"1999","journal-title":"Anticancer Res"},{"key":"key20240611104502_b28-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/bies.201500093","article-title":"Targeting tumor suppressor genes for cancer therapy","volume":"37","author":"Liu","year":"2015","journal-title":"Bioessays"},{"key":"key20240611104502_b29-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","article-title":"p53 research: The past thirty years and the next thirty years","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20240611104502_b30-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0165-4608(02)00929-9","article-title":"Chromosomal instability in osteosarcoma and its association with centrosome abnormalities","volume":"144","author":"Al-Romaih","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"key20240611104502_b31-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/09553000802195349","article-title":"P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2","volume":"84","author":"Zuffa","year":"2008","journal-title":"Int J Radiat Biol"},{"key":"key20240611104502_b32-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"627254","DOI":"10.1155\/2012\/627254","article-title":"The genetics of osteosarcoma","volume":"2012","author":"Martin","year":"2012","journal-title":"Sarcoma"},{"key":"key20240611104502_b33-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1158\/2159-8290.CD-22-0332","article-title":"TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: Biology, current therapy, and future directions","volume":"12","author":"Daver","year":"2022","journal-title":"Cancer Discov"},{"key":"key20240611104502_b34-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: Origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20240611104502_b35-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/bjh.13912","article-title":"TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation","volume":"172","author":"Middeke","year":"2016","journal-title":"Br J Haematol"},{"key":"key20240611104502_b36-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4103\/0019-509X.175843","article-title":"Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets","volume":"52","author":"Veldore","year":"2015","journal-title":"Indian J Cancer"},{"key":"key20240611104502_b37-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s12105-020-01223-2","article-title":"Osteosarcoma of the mandible in a patient with Florid Cemento-Osseous Dysplasia and Li-Fraumeni syndrome: A rare coincidence","volume":"15","author":"Haefliger","year":"2021","journal-title":"Head Neck Pathol"},{"key":"key20240611104502_b38-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1080\/10428194.2016.1225208","article-title":"Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing","volume":"58","author":"Pastoret","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"key20240611104502_b39-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.3390\/ijms22168885","article-title":"Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy","volume":"22","author":"Kryczka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20240611104502_b40-ol-28-1-14458","first-page":"324","article-title":"Expression and significance of PD-L1, Ki-67, TP53, and EGFR in lung adenocarcinoma tissues","volume":"36","author":"Xiangli","year":"2023","journal-title":"J Basic Clin Oncol"},{"key":"key20240611104502_b41-ol-28-1-14458","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00432-014-1630-6","article-title":"The prognostic role of matrix metalloproteinase 2 in gastric cancer: A systematic review with meta-analysis","volume":"140","author":"Shen","year":"2014","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:51:43Z","timestamp":1718092303000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,5,15]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14458","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"324"}}